If you live with Crohn’s disease or ulcerative colitis, you’ve probably had well-meaning advice thrown your way: try this cleanse, cut out that food group, take this supplement. Some of it is harmless. Some of it can actually work against you. Separating what is genuinely useful from what simply sounds convincing matters, especially when your gut is already under strain.
What do we mean by “gut health”?
“Gut health” usually refers to how well the digestive tract is functioning: the state of the gut lining (the inner surface of the intestine that absorbs nutrients and acts as a barrier), the balance of the microbiome (the trillions of bacteria and other microbes living in the digestive tract), and how calm or active the immune system is within that environment. In inflammatory bowel disease (IBD), all three of these are affected, which is why gut health advice aimed at the general population does not always apply in the same way.
Why myths matter for people with IBD
Misinformation isn’t just unhelpful, it can actively increase inflammatory load, delay appropriate treatment, or lead to unnecessary dietary restriction. Because IBD involves a genuine disruption of the immune system and gut lining, decisions based on inaccurate assumptions can have real consequences rather than simply being a waste of time.
The myths
Myth 1: “Detox” diets or juice cleanses clear toxins from the gut
The body already has an effective detoxification system, primarily the liver and kidneys. Juice cleanses and fasting-style “detoxes” do not remove toxins from the intestine, and in IBD they can mean inadequate energy and protein intake at a time when the body needs steady nourishment to support tissue repair and immune regulation.
Myth 2: All gut bacteria are bad and should be eliminated
The microbiome is not something to be wiped out, it is something to be supported. Many gut bacteria produce short-chain fatty acids, compounds made when bacteria ferment fibre, which help maintain the gut lining and have a calming effect on local immune activity. In IBD, the goal is a more balanced and diverse microbial community, not a sterile gut.
Myth 3: Probiotics work the same way for everyone
Probiotics are live microorganisms taken to support gut function, but strains, doses, and effects vary considerably. Evidence for probiotics in IBD is mixed and strain-specific; some may help maintain remission in ulcerative colitis, while others show little benefit in Crohn’s disease. They are not an interchangeable, one-size-fits-all fix, and should be discussed with a gastroenterologist or dietitian rather than chosen at random.
Myth 4: Gluten-free diets are healthier for everyone
Unless someone has coeliac disease or a diagnosed gluten sensitivity, there is no strong evidence that removing gluten improves gut inflammation in IBD. Cutting gluten unnecessarily can reduce dietary variety and fibre intake, both of which are usually more helpful to maintain than restrict.
Myth 5: If you have IBD, you should avoid fibre altogether
Fibre is often reduced during a flare, particularly if there is narrowing in the bowel, but this is a temporary and situation-specific measure, not a permanent rule. During remission, many people with IBD tolerate and benefit from fibre, since it feeds beneficial bacteria and supports stool consistency. Blanket, long-term fibre avoidance is not supported by current dietary guidance and may reduce microbiome diversity over time.
Myth 6: Stress is “all in your head” and doesn’t affect the gut
The gut and brain communicate constantly through the gut-brain axis, a two-way signalling system involving nerves, hormones, and immune messengers. Psychological stress can influence gut motility, pain sensitivity, and immune activity, and while stress does not cause IBD, it is associated with symptom flares and can lower quality of life. Addressing stress is a legitimate part of managing the condition, not a dismissal of physical symptoms.
Myth 7: Once symptoms disappear, the gut is fully healed
Symptoms and inflammation do not always move together. Someone can feel well while inflammation is still present at a microscopic level, and conversely, some symptoms (such as pain from previous scarring) can persist even when inflammation has settled. This is why gastroenterologists rely on objective markers, such as blood tests, faecal calprotectin, or endoscopy, rather than symptoms alone, to judge whether treatment is working.
Practical takeaways
- Treat dramatic claims (detoxes, miracle cures) with scepticism, particularly if they promise fast results.
- Discuss any probiotic or supplement use with your IBD team before starting.
- Avoid restrictive diets, including gluten-free or low-fibre eating, unless there is a specific medical reason.
- Reintroduce fibre gradually during remission rather than avoiding it indefinitely.
- Recognise stress management as a genuine part of IBD care, not an alternative to medical treatment.
- Continue attending monitoring appointments even when you feel well, since symptoms don’t always reflect what’s happening internally.
Conclusion
Good gut health information in IBD is built on consistency, not quick fixes or absolute rules. Many popular myths oversimplify a system that is genuinely complex, involving the gut lining, the microbiome, and the immune system working together. Being cautious about extreme claims, and checking dietary or lifestyle changes with a gastroenterologist or dietitian, helps protect both nutritional status and long-term gut stability. Managing IBD well is usually about steady, evidence-based habits maintained over time, rather than dramatic interventions.
References
- Sartor RB. Mechanisms of disease: pathogenesis of Crohn’s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol. 2006;3(7):390-407. doi:10.1038/ncpgasthep0528
- Rasmussen HE, Hamaker BR. Prebiotics and inflammatory bowel disease. Gastroenterol Clin North Am. 2017;46(4):783-795. doi:10.1016/j.gtc.2017.08.004
- Derwa Y, Gracie DJ, Hamlin PJ, Ford AC. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Aliment Pharmacol Ther. 2017;46(4):389-400. doi:10.1111/apt.14203
- Sigall-Boneh R, Levine A, Lomer M, et al. Research gaps in diet and nutrition in inflammatory bowel disease. J Crohns Colitis. 2017;11(12):1407-1419. doi:10.1093/ecco-jcc/jjx109
- Bonaz BL, Bernstein CN. Brain-gut interactions in inflammatory bowel disease. Gastroenterology. 2013;144(1):36-49. doi:10.1053/j.gastro.2012.10.003
- Mawdsley JE, Rampton DS. Psychological stress in IBD: new insights into pathogenic and therapeutic implications. Gut. 2005;54(10):1481-1491. doi:10.1136/gut.2005.064261
- D’Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18(12):2218-2224. doi:10.1002/ibd.22917
- Peyrin-Biroulet L, Sandborn W, Sands BE, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110(9):1324-1338. doi:10.1038/ajg.2015.233
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.